Editorial Comment from Dr Yokomizo to Efficacy of traditional and alternative sunitinib treatment schedules in Japanese patients with metastatic renal cell carcinoma

Akira Yokomizo

Research output: Contribution to journalComment/debatepeer-review

Fingerprint

Dive into the research topics of 'Editorial Comment from Dr Yokomizo to Efficacy of traditional and alternative sunitinib treatment schedules in Japanese patients with metastatic renal cell carcinoma'. Together they form a unique fingerprint.